CNP Ameliorates Macrophage Inflammatory Response and Atherosclerosis
Qiankun Bao(Second Hospital of Tianjin Medical University), Jinlong He(Xi'an Jiaotong University), Xiaofeng Mu(Second Hospital of Tianjin Medical University), Jingjin Che(Second Hospital of Tianjin Medical University), Ying Liu(Shanghai First Maternity and Infant Hospital), Guangping Li(Qingdao University), Wen Wei(Arizona State University), Lu Zhou(Second Hospital of Tianjin Medical University), Xing Liu(Hunan University of Science and Technology), Yue Zhang(Second Hospital of Tianjin Medical University), Qian Yang(Second Hospital of Tianjin Medical University), Meng Yuan(Second Hospital of Tianjin Medical University), Bangying Zhang(Second Hospital of Tianjin Medical University)
Cited by 46
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
|Cardiovascular Diabetology|2019|296
Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion
|Journal of the American College of Cardiology|2007|271